Contribution of maternal adherence to the effect of multiple micronutrient supplementation during pregnancy: a systematic review and individual participant data meta-analysis

Authors

Document Type

Journal Article

Publication Date

5-30-2025

Journal

Advances in nutrition (Bethesda, Md.)

DOI

10.1016/j.advnut.2025.100455

Keywords

antenatal care; individual participant data meta-analysis; multiple micronutrient supplements; pregnancy

Abstract

Multiple micronutrient supplements (MMS) in pregnancy reduces the risk of infant low birthweight (LBW) and improves other maternal and infant outcomes as compared to iron-folic acid supplements (IFA) alone. However, the impact of timing of initiation and adherence on the MMS effectiveness in real-world programs remains unclear. To address this, we conducted a two-stage individual participant data meta-analysis that included 15 randomized trials (61,204 pregnant women) and assessed whether the relative effect of MMS differed by: adherence alone; adherence in combination with gestational age at initiation; and the total number of tablets taken. We also evaluated the observational association of these factors with outcomes among participants who received MMS. Compared to IFA; the relative effect of MMS on the primary outcome of continuous birthweight was greater with higher adherence (p-value for interaction<0.05). Among women who took ≥90% of supplements, MMS increased birthweight by 56g (95%CI: 45, 67g), while among women who took <60% of supplements, there was no difference in birthweight between MMS and IFA (mean difference (MD): 9g; 95%CI: -17, 35). Higher adherence was also associated with greater effect of MMS on LBW and birthweight-for-gestational age centile and women who took more supplements experienced a greater relative impact of MMS on birthweight-for-gestational age centile and small-for-gestational age births (SGA) as compared to IFA. Observational analyses among participants who received MMS showed that ≥90% adherence was associated with increased birthweight (MD: 44g; 95%CI: 31, 56) and lower risk of LBW (RR: 0.93; 95%CI: 0.88, 0.98) and SGA (RR: 0.95; 95%CI: 0.93, 0.98), while <75% adherence was associated with a greater risk of stillbirth (RR: 1.43; 95%CI: 1.12, 1.83) and maternal anemia (RR: 1.26; 95%CI: 1.11, 1.43) as compared to 75-90% adherence. Programs should invest in strategies that promote early initiation and high adherence to MMS. PROSPERO ID: CRD42022319207 INTERNATIONAL PROSPECTIVE REGISTER OF SYSTEMATIC REVIEWS (PROSPERO) ID: CRD42022319207.

Department

Health, Human Function, and Rehabilitation Sciences

Share

COinS